NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today provided notice to holders of certain bonds have the right to convert the debentures.

The firm said that holders of Apogent Technologies' Floating Rate Convertible Senior Debentures due 2033 may convert the debentures because Thermo Fisher's stock has traded above the minimum price specified in the indenture over the applicable measurement period.

Thermo Fisher assumed the debentures as part of its acquisition of Apogent in 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.